Hindelang, M. ; Kirsch, F. & Leidl, R. Effectiveness of non-pharmacological COPD management on health-related quality of life-a systematic review. Expert Rev. Pharmacoecon. Outcomes Res. 20, 79-91 (2020)
Szentes, B.L. ; Schwarzkopf, L. ; Kirsch, F. ; Schramm, A.* & Leidl, R. Measuring quality of life in COPD patients: Comparing disease-specific supplements to the EQ-5D-5L. Expert Rev. Pharmacoecon. Outcomes Res. 20, 523-529 (2019)
Kirsch, F. A systematic review of quality and cost-effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease. Expert Rev. Pharmacoecon. Outcomes Res. 15, 301-316 (2015)
Kirsch, F. A systematic review of Markov models evaluating multicomponent disease management programs in diabetes. Expert Rev. Pharmacoecon. Outcomes Res. 15, 961-984 (2015)
Müller, D.* et al. Reporting health care decision models: A prospective reliability study of a multidimensional evaluation framework. Expert Rev. Pharmacoecon. Outcomes Res. 16, 619-627 (2015)
Becker, C. Cost-of-illness studies of atrial fibrillation: Methodological considerations. Expert Rev. Pharmacoecon. Outcomes Res. 14, 661-684 (2014)
John, J. & Teuner, C.M. Combating pediatric obesity in Germany: The role of economic findings in informing policy. Expert Rev. Pharmacoecon. Outcomes Res. 12, 733-743 (2012)
Becker, C. ; Langer, A. & Leidl, R. The quality of three decision-analytic diabetes models: A systematic health economic assessment. Expert Rev. Pharmacoecon. Outcomes Res. 11, 751-761 (2011)